Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing

Business Wire September 17, 2018

QIAGEN to Join Germany’s MDAX Index in Addition to TecDAX

Business Wire September 12, 2018

QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics

Business Wire August 1, 2018

QIAGEN’s careHPV™ Test Wins WHO Prequalification Status for Cervical Cancer Screening

Business Wire August 1, 2018

QIAGEN Reports Results for Second Quarter and First Half of 2018

Business Wire July 31, 2018

QIAGEN’s QuantiFERON-TB® Gold Plus Wins UN Migration Agency’s Tender

Business Wire July 30, 2018

QIAGEN and Hamilton Launch New Collaboration to Improve Pre-Analytical Sample Processing for QuantiFERON-TB Gold Plus

Business Wire July 30, 2018

QIAGEN N.V. to Report Second Quarter and First Half of 2018 Results

Business Wire July 17, 2018

QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis

Business Wire June 25, 2018

QIAGEN Welcomes New Guidelines from American Academy of Pediatrics for Detecting Tuberculosis Infection in Children

Business Wire June 4, 2018

Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO

Benzinga.com  June 1, 2018

QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018

Business Wire May 31, 2018

Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended

Benzinga.com  May 25, 2018

QIAGEN Welcomes WHO’s Essential Diagnostics List Which Includes QuantiFERON-TB Gold

Business Wire May 22, 2018

QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

Business Wire May 15, 2018

QIAGEN Reports Results for First Quarter 2018

Business Wire May 2, 2018

QIAGEN Announces FDA Approval of PartoSureTM

Business Wire April 20, 2018

QIAGEN announces European launch of QIAstat-Dx®, a next generation platform for syndromic insights

Business Wire April 19, 2018

QIAGEN posts 2017 Annual Report on Its website

Business Wire April 19, 2018

QIAGEN N.V. to Report First Quarter 2018 Results

Business Wire April 17, 2018